Status
Conditions
Treatments
About
The purpose of this study is to assess acceptability, and safety of providing tDCS to ADRD patients with behavioral symptoms and to assess the efficacy of tDCS for ADRD-related symptoms, mainly behavioral symptoms.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
20 participants in 1 patient group
Loading...
Central trial contact
Thiago Macedo e Cordeiro, MD; Kendra M Anderson, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal